Johnson & Johnson Investor Presentation — April 2019

Document content

April 16, 2019Cautionary Note on Forward -looking Statements

3This presentation contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regar ding, among other things: future

operating and financial performance, product development, market position and business strategy. The viewer is cautioned not to rely on these forward-looking

statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate o r known or unknown risks or

uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. R isks and uncertainties include, but are not

limited to: economic factors, such as interest rate and currency exchange rate fluctuations; competition, including technolog ical advances, new products and patents

attained by competitors; challenges inherent in new product research and development, including unexpected clinical trial res ults, additional analysis of existing clinical

data, uncertainty of clinical success and obtaining regulatory approvals; uncertainty of commercial success for new and exist ingproducts; the impact of business

combinations and divestitures; challenges to patents; the impact of patent expirations; the ability of the company to success fully execute strategic plans, including

restructuring plans; manufacturing difficulties or delays, internally or within the supply chain; product efficacy or safety concerns resulting in product recalls or regulatory

action; significant adverse litigation or government action, including related to product liability claims; changes to applic able laws and regulations, including tax laws,

global health care reforms and import/export and trade laws; trends toward health care cost containment; changes in behavior andspending patterns of purchasers of